Engagement of the private pharmaceutical sector for TB control: rhetoric or reality?

Abstract

BackgroundPrivate-sector retail drug outlets are often the first point of contact for common health ailments, including tuberculosis (TB). Systematic reviews on public-private mix (PPM) interventions for TB did not perform in-depth reviews specifically on engaging retail drug outlets and related stakeholders in the pharmaceutical sector. Our objective was to better understand the extent to which the World Health Organization’s (WHO) recommendation on engaging retail drug outlets has been translated into programmatic policy, strategy, and intervention in low- and middle-income countries.MethodsThe study included a content analysis of global-level documents from WHO and the Stop TB Partnership in five phases. A country-level content analysis from four data sources was performed. Global-level findings were tabulated based on key messages related to engaging retail drug outlets. Country-level findings were analyzed based on four factors and tabulated. National strategic plans for TB control from 14 countries with varying TB burdens and a strong private sector were reviewed.Results33 global-level documents and 77 full-text articles and Union World Lung Health conference abstracts were included for review. Based on experience of engaging retail drug outlets that has emerged since the mid-2000s, in 2011 WHO and the International Pharmaceutical Federation released a joint statement on promoting the engagement of national pharmacy associations in partnership with national TB programs. Only two of 14 countries’ national strategic plans had explicit statements on the need to engage their national pharmacy professional association. The success rate of referrals from retail drug outlets who visited an approved health facility for TB screening ranged from 48% in Vietnam to 86% in Myanmar. Coverage of retail drug outlets ranged from less than 5 to 9% of the universe of retail drug outlets.ConclusionsFor WHO’s End TB Strategy to be successful, scaling up retail drug outlets to increase national coverage, at least in countries with a thriving private sector, will be instrumental in accelerating the early detection and referral of the 3 million missing TB cases. The proposed PPM pharmacy model is applicable not only for TB control but also to tackle the antimicrobial resistance crisis in these countries.Electronic supplementary materialThe online version of this article (doi:10.1186/s40545-016-0093-3) contains supplementary material, which is available to authorized users.

Can community pharmacists improve tuberculosis case finding? A mixed methods intervention study in India

“…Private pharmacies in India have been engaged in TB treatment education, and screening and referral initiatives within PPM projects but participation has been low 17–20. In 2013, the RNTCP recommended pharmacists actively triage and refer patients presenting with cough longer than 2 weeks to microscopy centres for sputum testing 21.…”

A survey of knowledge, attitude, and practices of private retail pharmacies staff in tuberculosis care: study from Dera Ismail Khan City, Pakistan

“…Retail pharmacies usually have close links to the society, and not only dispense prescriptions for anti-TB drugs, but are often the first point of contact for people with symptoms of TB. Experiences in many countries have revealed that with proper training, the retail pharmacy staff has the potential to play an important role in TB case management and detection [ 9 ]. WHO has recognized pharmacists as one of the six pillars for providing efficient TB care with International Pharmaceutical Federation and have stressed the need for intense collaborative exercise [ 10 ].…”

Quality of tuberculosis care by Indian pharmacies: Mystery clients offer new insights

“…Over the past decade, there have been projects focused on engaging pharmacists in India [13]. But such public-private mix (PPM) partnerships are yet to reach scale [14]. In the most recent draft of the National Strategic Plan for Tuberculosis Elimination 2017–2025, there are no budgets for engaging retail pharmacists, but mapping of pharmacies and their engagement is surveillance and social mobilization is envisioned [15].…”